AbCellera Biologics Inc.

NASDAQ: ABCL · Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT

AbCellera Biologics Statistics

Share Statistics

AbCellera Biologics has 298.49M shares outstanding. The number of shares has increased by 1.3% in one year.

298.49M
1.3%
0.17%
41.9%
224.1M
31,366
0.49%

Short Selling Information

The latest short interest is 35.72M, so 11.97% of the outstanding shares have been sold short.

35.72M
11.97%
15.53%
5.76

Valuation Ratios

The PE ratio is -5.3 and the forward PE ratio is -9.28. AbCellera Biologics's PEG ratio is -0.68.

-5.3
-9.28
29.91
19.3
0.82
-4.61
-0.68
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AbCellera Biologics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.06.

9.81
9.81
0.06
-0.32
-0.35
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$48.38K
$-273.25K
596
0.02
n/a

Taxes

-37.54M
18.73%

Stock Price Statistics

The stock price has increased by 70.45% in the last 52 weeks. The beta is 0.65, so AbCellera Biologics's price volatility has been higher than the market average.

0.65
70.45%
3.74
2.95
50.33
6,401,375

Income Statement

In the last 12 months, AbCellera Biologics had revenue of 28.83M and earned -162.86M in profits. Earnings per share was -0.55.

28.83M
-68.17M
-314.77M
-162.86M
-204.15M
-301.15M
-0.55
Full Income Statement

Balance Sheet

The company has 156.32M in cash and 65.36M in debt, giving a net cash position of 90.96M.

156.32M
65.36M
90.96M
116.93M
1.34B
689.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -108.56M and capital expenditures -78.4M, giving a free cash flow of -186.95M.

-108.56M
-78.4M
-186.95M
-0.64
Full Cash Flow Statement

Margins

Gross margin is -236.42%, with operating and profit margins of -1091.69% and -564.83%.

-236.42%
-1091.69%
-695.02%
-564.83%
-708.04%
-1091.69%
-648.4%

Dividends & Yields

ABCL does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ABCL is $8.5, which is 88.9% higher than the current price. The consensus rating is "Buy".

$8.5
88.9%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

2.34
2